Detection of herpesvirus EBV DNA in the lower respiratory tract of ICU patients: a marker of infection of the lower respiratory tract?

AbstractEpstein-Barr virus (EBV) is a lymphotropic herpesvirus causing clinically self-limiting but lifelong persisting infections. Although several severe diseases (e.g., Hodgkin′s disease) are associated with EBV, its role in lower respiratory tract infections is still elusive. The prevalence of EBV, herpes simplex virus (HSV) and cytomegalovirus (CMV) in bronchoalveolar fluid (BAL) samples was evaluated in a retrospective study. BAL samples from 135 patients in the intensive or coronary care unit (ICU/ICC) at University Hospital Frankfurt/Main (Germany) were investigated using an in-house real-time PCR to detect EBV-, HSV- and CMV-specific DNA. Overall, herpesvirus DNA was detected in n = 82/135 BAL samples (60.7 %). Besides mono-infections with either EBV or HSV, concomitant infection with EBV and HSV DNA was most frequent, whereby the relative HSV viral load was typically higher. Patients with HSV-positive BAL required mechanical ventilation on average 5 days longer than patients with HSV-negative BAL (p = 0.006). Additionally, the proinflammatory cytokine IL-6 was significantly elevated in sera of patients positive for EBV in comparison with patients with EBV-negative BAL (p = 0.01). This study demonstrates a high prevalence of herpesviruses in BAL samples of ICU/ICC patients. The detection of one or more herpesvirus in BAL is strongly associated with the duration of ventilation and patient′s age. The association between IL-6 levels and EBV detection should be evaluated in further studies.

[1]  R. Friedrich,et al.  Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma , 2003, Medical Microbiology and Immunology.

[2]  S. Webber,et al.  Screening for PTLD in lung and heart–lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR , 2008, Pediatric transplantation.

[3]  J. Otte,et al.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis , 2012, Medical Microbiology and Immunology.

[4]  E. Bouza,et al.  Herpes simplex virus: a marker of severity in bacterial ventilator-associated pneumonia. , 2011, Journal of critical care.

[5]  Kai A. Kropp,et al.  Viral latency drives ‘memory inflation’: a unifying hypothesis linking two hallmarks of cytomegalovirus infection , 2012, Medical Microbiology and Immunology.

[6]  L. Chiche,et al.  The role of viruses in nosocomial pneumonia , 2011, Current opinion in infectious diseases.

[7]  C. Bolliger,et al.  Diagnostic yield of bronchoalveolar lavage following renal transplantation , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  S. Baldi,et al.  Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. , 2010, Transplantation proceedings.

[9]  H. Einsele,et al.  Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia , 2009, Bone Marrow Transplantation.

[10]  M. Lung,et al.  EVIDENCE THAT RESPIRATORY TRACT IS MAJOR RESERVOIR FOR EPSTEIN-BARR VIRUS , 1985, The Lancet.

[11]  R. Cavallo,et al.  Clinical impact of HSV-1 detection in the lower respiratory tract from hospitalized adult patients. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  H. Kanegane,et al.  Cytokine profiles in children with primary Epstein–Barr virus infection , 2013, Pediatric blood & cancer.

[13]  C. Sam,et al.  Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma , 2006, BMC Cancer.

[14]  H. Doerr,et al.  Measurement of CMV DNA Levels and CMV-Specific CD4+ Lymphocyte Counts in Patient Specimens: Requirements for Test Quality and Practicability in a Routine Diagnostic Service , 2003 .

[15]  T. Yoshikawa,et al.  High incidence of cytomegalovirus, human herpesvirus‐6, and Epstein–Barr virus reactivation in patients receiving cytotoxic chemotherapy for Adult T cell leukemia , 2011, Journal of medical virology.

[16]  P. Ljungman Molecular monitoring of viral infections after hematopoietic stem cell transplantation , 2010, International journal of hematology.

[17]  P. Delvenne,et al.  Herpes simplex virus reactivation and dental procedures , 2013, Clinical Oral Investigations.

[18]  A. Heim,et al.  Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient , 2010, Medical Microbiology and Immunology.

[19]  K. Peck,et al.  An Adult Case of Chronic Active Epstein-Barr Virus Infection with Interstitial Pneumonitis , 2011, The Korean journal of internal medicine.

[20]  S. Baldi,et al.  Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients. , 2011, Transplantation proceedings.

[21]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[22]  R. Cavallo,et al.  Quantitative Detection of Epstein-Barr Virus in Bronchoalveolar Lavage From Transplant and Nontransplant Patients , 2008, Transplantation.

[23]  D. Hébert,et al.  Exploring beyond viral load testing for EBV lymphoproliferation: Role of serum IL‐6 and IgE assays as adjunctive tests , 2010, Pediatric transplantation.

[24]  V. Smit,et al.  Quantitative detection of herpes simplex virus DNA in the lower respiratory tract , 2007, Journal of medical virology.